Anavex Life Sciences Corp.

Nasdaq AVXL · New York, NY

Works in Genetic & rare · Neurology · Psychiatry

Anavex Life Sciences Corp. is a clinical trial sponsor based in New York, NY, listed as Nasdaq AVXL. It has 1 active clinical trial with 71 planned participants, in Genetic & rare, Neurology and Psychiatry. Since 2021 it has completed 8 trials and stopped 0 early.

Trial track record · since 2021

1Active trials71 planned participants
8Completed0 with results posted
0Stopped early0% of finished trials

Financials · Nasdaq AVXL

Cash and equivalents
R&D expense
Net income (loss)
Cash runway

Pipeline · 1 active trial

StageTrialStatus

Questions about Anavex Life Sciences Corp

See the rest of this profile

A free account shows the trial list, the financials and the fundraising filings. Pro adds a watchlist: one email when FDA acts on a company you name.

Trial counts are as the sponsor reported them to ClinicalTrials.gov, for trials changed since 2021; latest update 2025-05-04.

Approve Suite is not affiliated with Anavex Life Sciences Corp..

See something wrong on this page? Write to info@approvesuite.com and we will check it against the source. How corrections work.